Angewandte Chemie · 2015 · 31 citations · 28 references
PharmacyOncologyPharmaceuticsCancer PharmacologyDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignTumor-activated ProdrugsBiomedical ApplicationsEnzyme Activity RetentionEnzyme Delivery SystemsIntravital MicroscopyNanocarrier-based ProdrugsNanoparticle-delivered ProdrugsPolymeric VesiclesTumor Tissue Targeting
Abstract The design and construction of nanoreactors are important for biomedical applications of enzymes, but lipid‐ and polymeric‐vesicle‐based nanoreactors have some practical limitations. We have succeeded in preparing enzyme‐loaded polyion complex vesicles (PICsomes) through a facile protein‐loading method. The preservation of enzyme activity was confirmed even after cross‐linking of the PICsomes. The cross‐linked β‐galactosidase‐loaded PICsomes (β‐gal@PICsomes) selectively accumulated in the tumor tissue of mice. Moreover, a model prodrug, HMDER‐βGal, was successfully converted into a highly fluorescent product, HMDER, at the tumor site, even 4 days after administration of the β‐gal@PICsomes. Intravital confocal microscopy showed continuous production of HMDER and its distribution throughout the tumor tissues. Thus, enzyme‐loaded PICsomes are useful for prodrug activation at the tumor site and could be a versatile platform for enzyme delivery in enzyme prodrug therapy.
28
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Horacio Cabral, Yu Matsumoto, Kazue Mizuno et al. · Nature Nanotechnology · 2011 · 2.4K citations
Pharmacy, Oncology, Pharmacokinetics +14